Tlhaloso e qaqileng
Hepatitis A e bakoa ke kokoana-hloko ea hepatitis A (HAV) 'me e fetisoa haholo-holo ke tsela ea molomo, haholo-holo ho tsoa ho bakuli.Nako ea ho futhumala ha lefu la sebete la A ke matsatsi a 15-45, 'me kokoana-hloko e atisa ho ba teng maling le mantleng a mokuli matsatsi a 5-6 pele transcarbidine e phahama.Kamora libeke tse 2-3 tsa ho qala, ka tlhahiso ea li-antibodies tse khethehileng serum, ts'oaetso ea mali le mantle e nyamela butle-butle.Nakong ea tšoaetso e totobetseng kapa ea boloi ea lefu la sebete la A, 'mele o ka hlahisa li-antibodies.Ho na le mefuta e 'meli ea li-antibodies (anti-HAV) ka har'a serum, anti-HAVIgM le anti-HAVIgG.Anti-HAVIgM e hlaha kapele, hangata e lemohuoa matsatsing a seng makae ka mor'a ho qala, 'me nako ea jaundice e phahama, e leng sesupo sa bohlokoa bakeng sa tlhahlobo ea pele ea lefu la sebete la A. Anti-HAVIgG e bonahala e le morao 'me e nka nako e telele, hangata e le mpe qalong ea tšoaetso,' me anti-HAVIgG positive e bontša tšoaetso e fetileng ea HAV 'me hangata e sebelisoa lipatlisisong tsa lefu la seoa.Tlhahlobo ea likokoana-hloko ea lefu la sebete la A e thehiloe haholo-holo ho li-antigen le li-antibodies tsa kokoana-hloko ea lefu la sebete la A.Mekhoa ea kopo e kenyelletsa microscope ea immunoelectron, complement binding test, immunoadhesion hemagglutination test, solid-phase radioimmunoassay le enzyme-linked immunosorbent assay, polymerase chain reaction, cDNA-RNA molecular hybridization technology, joalo-joalo.
Litaba tse ikhethileng
Ts'ebetso ea Tlhahiso e Potlakileng ea Leqephe le sa Hlakoang
